Literature DB >> 19121768

Burnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus.

Kamyar Kalantar-Zadeh1, Stephen F Derose, Susan Nicholas, Deborah Benner, Kumar Sharma, Csaba P Kovesdy.   

Abstract

Many individuals with diabetic nephropathy, the leading cause of chronic kidney disease (CKD) in the United States, progress to stage 5 of CKD and undergo maintenance dialysis treatment. Recent data indicate that in up to one third of diabetic dialysis patients with a presumptive diagnosis of diabetic nephropathy, glycemic control improves spontaneously with the progression of CKD, loss of residual renal function, and the initiation of dialysis therapy, leading to normal-to-low hemoglobin A1c (<6%) and glucose levels, requiring cessation of insulin or other anti-diabetic medications. Potential contributors to this so-called "burnt-out diabetes" include decreased renal and hepatic insulin clearance, a decline in renal gluconeogenesis, deficient catecholamine release, diminished food intake (because of anorexia or diabetic gastroparesis), protein-energy wasting (with resultant loss of weight and body fat), and the hypoglycemic effects of dialysis treatment. Although the concept of "burnt-out diabetes" appears in sharp contradistinction to the natural history of diabetes mellitus, studying this condition and its potential causes and consequences, including the role of genetic factors, may lead to a better understanding of the pathophysiology of metabolic syndrome and diabetes mellitus in the CKD population and in many other individuals with chronic disease states associated with wasting syndrome that can confound the natural history of diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19121768      PMCID: PMC2652655          DOI: 10.1053/j.jrn.2008.11.012

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  30 in total

Review 1.  Impact of end-stage renal disease and dialysis on glycemic control.

Authors:  R H Mak
Journal:  Semin Dial       Date:  2000 Jan-Feb       Impact factor: 3.455

2.  Excerpts from the United States Renal Data System 2006 Annual Data Report.

Authors:  Allan J Collins; Bertram Kasiske; Charles Herzog; Blanche Chavers; Robert Foley; David Gilbertson; Richard Grimm; Jiannong Liu; Thomas Louis; Willard Manning; Marshall McBean; Anne Murray; Wendy St Peter; Jay Xue; Qiao Fan; Haifeng Guo; Qi Li; Shuling Li; Yang Qiu; Suying Li; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; Rui Zhang; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Delaney Berrini; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2007-01       Impact factor: 8.860

3.  An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.

Authors:  Shervin Eshaghian; Tamara B Horwich; Gregg C Fonarow
Journal:  Am Heart J       Date:  2006-01       Impact factor: 4.749

4.  A1C and survival in maintenance hemodialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Joel D Kopple; Deborah L Regidor; Jennie Jing; Christian S Shinaberger; Jason Aronovitz; Charles J McAllister; David Whellan; Kumar Sharma
Journal:  Diabetes Care       Date:  2007-03-02       Impact factor: 19.112

5.  Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis.

Authors:  T P Peacock; Z K Shihabi; A J Bleyer; E L Dolbare; J R Byers; M A Knovich; J Calles-Escandon; G B Russell; B I Freedman
Journal:  Kidney Int       Date:  2008-02-20       Impact factor: 10.612

Review 6.  Glycemic control in diabetic CKD patients: where do we stand?

Authors:  Csaba P Kovesdy; Kumar Sharma; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2008-06-24       Impact factor: 8.860

7.  A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.

Authors:  D Fouque; K Kalantar-Zadeh; J Kopple; N Cano; P Chauveau; L Cuppari; H Franch; G Guarnieri; T A Ikizler; G Kaysen; B Lindholm; Z Massy; W Mitch; E Pineda; P Stenvinkel; A Treviño-Becerra; A Trevinho-Becerra; C Wanner
Journal:  Kidney Int       Date:  2007-12-19       Impact factor: 10.612

8.  Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome.

Authors:  Arthur J Matas; Kristen J Gillingham; Abhinav Humar; Hassan N Ibrahim; William D Payne; Rainer W G Gruessner; Ty B Dunn; David E R Sutherland; John S Najarian; Raja Kandaswamy
Journal:  Transplantation       Date:  2008-02-15       Impact factor: 4.939

Review 9.  Glucose in the dialysate: historical perspective and possible implications?

Authors:  Rajiv Sharma; Mitchell H Rosner
Journal:  Hemodial Int       Date:  2008-04       Impact factor: 1.812

10.  Significant correlation of glycated albumin, but not glycated haemoglobin, with arterial stiffening in haemodialysis patients with type 2 diabetes.

Authors:  Yasuro Kumeda; Masaaki Inaba; Shigeichi Shoji; Eiji Ishimura; Hiromi Inariba; Sachiko Yabe; Mikio Okamura; Yoshiki Nishizawa
Journal:  Clin Endocrinol (Oxf)       Date:  2008-01-31       Impact factor: 3.478

View more
  26 in total

Review 1.  Dietary restrictions in dialysis patients: is there anything left to eat?

Authors:  Kamyar Kalantar-Zadeh; Amanda R Tortorici; Joline L T Chen; Mohammad Kamgar; Wei-Ling Lau; Hamid Moradi; Connie M Rhee; Elani Streja; Csaba P Kovesdy
Journal:  Semin Dial       Date:  2015-02-03       Impact factor: 3.455

Review 2.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

3.  Diabetics on hemodialysis in El-Minia Governorate, Upper Egypt: five-year study.

Authors:  Osama El-Minshawy; Emad G Kamel
Journal:  Int Urol Nephrol       Date:  2010-03-09       Impact factor: 2.370

Review 4.  Glycemic control and burnt-out diabetes in ESRD.

Authors:  Csaba P Kovesdy; Jong C Park; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2010-03-30       Impact factor: 3.455

Review 5.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

6.  Correlates of low hemoglobin A1c in maintenance hemodialysis patients.

Authors:  Youngmee Kim; Jong Chan Park; Miklos Z Molnar; Anuja Shah; Debbie Benner; Csaba P Kovesdy; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Int Urol Nephrol       Date:  2012-06-09       Impact factor: 2.370

7.  Assessment of hepatic insulin extraction from in vivo surrogate methods of insulin clearance measurement.

Authors:  Isaac Asare-Bediako; Rebecca L Paszkiewicz; Stella P Kim; Orison O Woolcott; Cathryn M Kolka; Miguel Burch; Morvarid Kabir; Francesca Piccinini; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-06       Impact factor: 4.310

Review 8.  Updates on the management of diabetes in dialysis patients.

Authors:  Connie M Rhee; Angela M Leung; Csaba P Kovesdy; Katherine E Lynch; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2014-03       Impact factor: 3.455

9.  HbA1c and survival in maintenance hemodialysis patients with diabetes in Han Chinese population.

Authors:  Xiurong Li; Xianlin Xu; Jinfeng Liu; Junwei Yang; Li Fang; Liying Miao; Jia Di; Xiaozhou He
Journal:  Int Urol Nephrol       Date:  2014-06-26       Impact factor: 2.370

10.  Association of hemodialysis treatment time and dose with mortality and the role of race and sex.

Authors:  Jessica E Miller; Csaba P Kovesdy; Allen R Nissenson; Rajnish Mehrotra; Elani Streja; David Van Wyck; Sander Greenland; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2009-10-22       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.